profit from every $100 of sales.
$0$100
Vivani Medical
$1.01+2.70% today
-25.7% in 1 year
1-year low $0.941-year high $1.60
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Vivani Medical sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $0 in 2025, with -$26.6 million of profit last year.
SalesProfit
Vivani Medical vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Vivani Medical | No profit yet | ||
 Boston Scientific | 22.2× · Fair price | ||
 Koninklijke Philips | 30.1× · Expensive | ||
 Steris | 32.8× · Expensive | ||
 Zimmer Biomet Holdings | 27.7× · Fair price |
AI analysis
An AI analyst reads Vivani Medical's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | |
| – | – | – | – | |
| -21 | -27 | -25 | -28 | |
| -21 | -27 | -24 | -27 | |
| -14 | -26 | -23 | -27 | |
| -0.36 | -0.50 | -0.43 | -0.43 | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 51 | 46 | 42 | 39 |
| Cash | 45 | 21 | 18 | 16 |
| Total debt | 1 | 21 | 19 | 19 |
| Total liabilities | 7 | 25 | 24 | 24 |
| 44 | 21 | 18 | 16 | |
| 38 | 51 | 55 | 62 | |
| -37.1% | -51.4% | -52.8% | -62.9% | |
| -31.3% | -123.6% | -133.4% | -169.2% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -19 | -24 | -21 | -24 | |
| 0 | 1 | 1 | 1 | |
| -19 | -25 | -21 | -25 | |
| Dividends paid | – | – | – | – |
| – | – | – | 0 | |
| 1 | 2 | 2 | 1 |
Valuation
- –
- –
- –
- 5.6×
- –
- –
- –
- -28.0%
- -29.2%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -74.4%
- -106.4%
- -264.0%
- -64.0%
- -78.2%
- –
Growth
- –
- –
- −19.4%
- –
- +14.5%
Financial health
- 0.1×
- 0.96
- 43.1%
- –
- 3.18
- 3.18
- 0.00
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 2%of 952
Bottom 20%of 884
Bottom 2%of 987
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 13, 2026 | -0.08 | -0.08 | +0.0% |
| Mar 26, 2026 | -0.09 | -0.09 | +0.0% |
| Nov 13, 2025 | -0.11 | -0.12 | +8.3% |
| Aug 13, 2025 | -0.12 | -0.10 | −20.0% |
| May 13, 2025 | -0.11 | -0.10 | −10.0% |
| Mar 31, 2025 | -0.11 | -0.10 | −10.0% |
| Nov 13, 2024 | -0.11 | -0.11 | +0.0% |
| Aug 13, 2024 | -0.10 | -0.12 | +16.7% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
25No pass
Benjamin Graham
34No pass
Philip Fisher
34No pass
Peter Lynch
44No pass
Joel Greenblatt
0No pass
Charlie Munger
25No pass
Terry Smith
30No pass
Questions about Vivani Medical
Is Vivani Medical a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Vivani Medical AI analysis
What does Vivani Medical do?
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It is in Medical - Devices.
Does Vivani Medical pay a dividend?
No. Vivani Medical does not pay a dividend at the moment; in 2025 it returned $28,000 to shareholders by buying back its own shares.
Is Vivani Medical stock halal?
Yes. Vivani Medical passes our halal screen: its business is permitted and its debt is 21% of its market value, under the 30% limit. How we check
How has Vivani Medical stock done over the past year?
Down 25.7% over the past twelve months, to $1.01. It traded between $0.94 and $1.60 and is 36.9% below its high.
Who are Vivani Medical's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Vivani Medical's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.